HIV-1 Infection Induces Interleukin-1β Production via TLR8 Protein-dependent and NLRP3 Inflammasome Mechanisms in Human Monocytes by Guo, Haitao et al.
HIV-1 Infection Induces Interleukin-1 Production via TLR8
Protein-dependent and NLRP3 Inflammasome Mechanisms in
Human Monocytes*
Received for publication, March 23, 2014, and in revised form, June 14, 2014 Published, JBC Papers in Press, June 17, 2014, DOI 10.1074/jbc.M114.566620
Haitao Guo‡, Jianmei Gao‡, Debra J. Taxman‡§, Jenny P. Y. Ting‡§, and Lishan Su‡§1
From the ‡Lineberger Comprehensive Cancer Center and §Department of Microbiology and Immunology, University of North
Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Background: Inflammation is associated with HIV-1 pathogenesis and the progression of AIDS.
Results: HIV-1 induces pro-IL-1 expression through Toll-like receptor 8 and caspase-1 activation through nucleotide-binding
domain, leucine-rich repeat containing protein 3 (NLRP3) inflammasome.
Conclusion: Both TLR8 and NLRP3 are required for HIV-1-induced IL-1 production in monocytes.
Significance: Knowing the mechanism of HIV-1-induced IL-1 is important for understanding systematic inflammation in
HIV-1 patients.
The induction of inflammatory cytokines such as IL-1 is
associated with the progression of human immunodeficiency
virus, type 1 (HIV-1) disease or AIDS. Unlike most inflamma-
tory cytokines that are regulated by NF-B at the transcriptional
level, production of mature IL-1 also depends on inflam-
masome activation. The mechanism by which HIV-1 induces
pro-IL-1 expression and activates inflammasomes to cleave
pro-IL-1 into its bioactive form is not clearly defined. We
report here that HIV-1 infection in human monocytes effi-
ciently induced IL-1 expression and inflammasome activation.
Toll-like receptor 8 (TLR8) was required for inducing pro-IL-1
expression, whereas the NLRP3 inflammasome was required for
IL-1 maturation and release. Furthermore, the lysosomal pro-
tease cathepsin B and HIV-1 induced production of reactive
oxygen species were critical for HIV-induced inflammasome
activation and IL-1 production. HIV-1 entry, reverse tran-
scription, and integration were all required for both pro-IL-1
expression and inflammasome activation. Finally, we show that
HIV-1-derived RNA was sufficient to induce both pro-IL-1
expression and inflammasome activation. We conclude that
HIV-1 infection induced the expression of pro-IL-1 via TLR8-
mediated mechanisms and activated caspase-1 through the
NLRP3 inflammasome to cleave pro-IL-1 into bioactive IL-1.
These findings help to elucidate mechanisms of HIV-1 disease
progression and identify novel targets for treating HIV-1
induced inflammation and immune activation.
Human immunodeficiency virus, type 1 (HIV-1)2 disease
progression is characterized by persistent inflammation and
chronic immune activation, which has been proposed to con-
tribute to the development of AIDS (1, 2). However, the precise
mechanism by which HIV-1 causes inflammation and immune
activation remains poorly understood. The microbial translo-
cation from the gut to the blood circulation because of the loss
of mucosal integrity during HIV-1 disease progression has been
proposed to be a possible contributing factor (3). A recent
report has also shown that repeated treatment with a TLR7/8
agonist alone can induce AIDS-like disease, including elevated
proinflammatory cytokines and lymphoid organ disruption (4).
Pathogen-associated molecular patterns are recognized by
specific receptors of the host innate immune system, including
Toll-like receptors (TLRs), C-type lectin receptors, retinoic
acid-inducible gene I-like receptors, and nucleotide-binding
domain, leucine-rich repeat-containing (NLR) proteins (5–7).
The HIV-1 genomic RNA has been reported to activate TLR7
or TLR8 in different cell types (8 –12). It is not clear whether
other TLRs, retinoic acid-inducible gene I-like receptors, or
NLRs are also activated by HIV-1 infection.
IL-1 plays a pivotal role in driving inflammation by binding
to the IL-1 receptor to induce more proinflammatory cyto-
kines. Its production is tightly controlled by two steps: induc-
tion of pro-IL-1 gene expression and caspase-1-mediated pro-
IL-1 cleavage (13). Inflammasome complexes regulate the
cleavage of pro-IL-1 by assembling into a multicomponent
protein platform, which leads to the activation of pro-caspase 1
(14). Several inflammasome complexes have been described to
date, defined by the presence of the NLR proteins NLRP1,
NLRP3, NLRC4, NLRP6, and NLRP12 and the pyrin and
HIN200 domain-containing protein AIM2 (15). The NLRP3
inflammasome is the most extensively studied and seems to
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natures (16 –21). Several types of viruses, including influenza A
virus, dengue virus, hepatitis C virus, adenovirus, varicella zos-
ter virus, encephalomyocarditis virus, vesicular stomatitis
virus, myxoma virus, and respiratory syncytial virus have been
found to induce IL-1 through the NLRP3 inflammasome (22–
31). Interestingly, HIV-1 infection has been reported to induce
NLRP3 mRNA expression in monocyte-derived dendritic cells
(32), and an SNP at the 3 UTR of the NLRP3 gene is associated
with susceptibility to HIV-1 infection (33). However, it is not
clear whether HIV-1 infection leads to activation of the NLRP3
inflammasome.
In this report, we found that HIV-1 infection induced IL-1
production and caspase-1 activation in human monocytes.
Using the siRNA approach, we showed that TLR8, but not
TLR7, was required for the induction of pro-IL-1 expression
and that the NLRP3 inflammasome was required for IL-1 mat-
uration and release. We found that reactive oxygen species
(ROS) were increased in the HIV-1-infected monocytic cells,
which was also critical for HIV-induced IL-1 production.
Cathepsin B, a lysosomal protease that has been reported to be
an activator of NLRP3 (34, 35), was also important for HIV-1-
induced IL-1 production. HIV-1 entry, reverse transcription,
and integration were all required for both pro-IL-1 expression
and caspase-1 activation. Finally, we found that HIV-1 derived
RNA was sufficient to induce both pro-IL-1 expression and
caspase-1 activation. We conclude that HIV-1 infection
induced IL-1 production by induction of pro-IL-1 through a
TLR8-dependent mechanism and activation of the NLRP3
inflammasome involving ROS and cathepsin B induction.
EXPERIMENTAL PROCEDURES
Cell Culture—The human monocytic cell line THP-1 was
maintained in RPMI 1640 medium (Invitrogen) containing 10%
FBS and 1% penicillin/streptomycin. THP-1 cells containing
scramble shRNA or shRNA for NLRP3, ASC, NLRC4 (36, 37),
MyD88 mutants, MyD88, TRAF6 mutants, TRAF6 (38), TLR7,
and TLR8 were cultured under the same conditions as THP-1,
as described previously. Human peripheral blood mononuclear
cells (PBMCs) were isolated from the buffy coat by Ficoll-Paque
Plus and maintained in RPMI 1640 medium containing 10%
FBS, 1% penicillin/streptomycin, and 1% nonessential amino
acids. Primary human monocytes were isolated from PBMCs by
negative selection using the human monocyte enrichment kit
from Stemcell Technologies and were maintained in Iscove’s
modified Dulbecco’s medium containing 10% FBS, 1% penicil-
lin/streptomycin, and 1% nonessential amino acids. Primary
human macrophages were differentiated from monocytes by
culturing in medium containing 20 ng/ml recombinant human
monocyte colony-stimulating factor (PeproTech, Rock Hill, NJ)
for 7 days. All cells were maintained at 37 °C in 5% carbon
dioxide.
Reagents and Antibodies—Z-VAD-fmk, Ac-YVAD-CHO,
(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid (APDC) and
CA-074 Me were from Enzo Life Sciences (Farmingdale, NY).
Chloroquine, ssRNA40, and ssRNA41 were from Invivogen
(San Diego, CA). Soluble CD4, enfuvirtide (T20), nevirapine
(NVP), zidovudine (AZT), raltegravir, and amprenavir were
from the National Institutes of Health AIDS Research and Ref-
erence Reagent Program. Antibodies used for immunoblotting
included anti-IL-1 (catalog no. 2022, Cell Signaling Technol-
ogy, Danvers, MA) and anti-caspase-1 p10 (catalog no. sc-515,
Santa Cruz Biotechnology, Santa Cruz, CA).
Preparation of the shRNA Plasmid and Cell Lines for TLR
Knockdown—The human 7 SK RNA polymerase III promoter
and the shRNA sequence for human TLR7 and TLR8 were
amplified by PCR from plasmid psiRNA-TLR7, psiRNA-TLR8
from Invivogen and inserted into lentiviral vector FG12 by XhoI
and XbaI. Lentiviruses were made by cotransfection of lentivi-
ral vector, VSVG, and NRF into 293T cells. THP-1 cells were
infected by lentiviruses containing shRNA for TLR7 or TLR8 by
spinoculation (5500 rpm and 25 °C for 3 h) to generate the
TLR7 or TLR8 knockdown cell line. Transduced cells were
sorted by the GFP marker.
Virus Propagation—293T cells were transfected with the
HIV-R3A proviral plasmid, and the cell-free supernatant was
collected and filtered with a 0.45-M filter. HIV-1 p24 was
measured by p24 ELISA. SupT1 cells were infected by 293T-
derived viruses, and cell-free supernatants were collected and
filtered on different days after infection. PBMCs were cultured
in medium containing 5 g/ml phytohemagglutinin and 20
units/ml IL-2 for 3 days and then infected with 293T-derived
viruses for 3 h. PBMCs were maintained in medium containing
20 units/ml IL-2, and cell-free supernatants were collected and
filtered on different days after infection. HIV p24 was measured
for SupT1- and PBMC-derived viral stocks, and supernatants
containing more than 100 ng/ml of p24 were used. The infec-
tious unit was determined by infecting the Magi-R5 reporter
cell line (39). The infectivity of the viral stock was about 1  104
infectious units/ng p24.
HIV-1 Infection of Human Primary Cells and Cell Lines—4 
105 THP-1 cells were incubated with 20 ng of p24 (SupT1-
derived HIV-1 stocks, multiplicity of infection of 0.5) plus 8
g/ml of Polybrene for 10 min at room temperature, and then
spinoculation was performed at 900  g at 37 °C for 3 h. 4  105
human primary monocytes were incubated with PBMC-de-
rived HIV-1 stocks (20 ng of p24, multiplicity of infection of 0.5)
as above. Cells were then washed three times and divided into
96-well plates with 105 cells/well in triplicate wells. Human
macrophages were cultured in 96-well plates with 105 cells/well
and infected with PBMC-derived HIV-1 (10 ng of p24, multi-
plicity of infection of 1) plus 8 g/ml of Polybrene for 3 h. Cells
were then washed three times with medium. For pharmacolog-
ical assessments, cells were treated with Z-VAD-fmk (25 or 50
M), Ac-YVAD-CHO (25 or 50 M), APDC (100 M), CA-074
Me (25 M), T20 (10 g/ml), NVP (2 M), AZT (5 M), ralte-
gravir (10 M), and amprenavir (10 M) for 1 h before infection
and then cultured in the presence of those drugs. For blocking
viral entry, viruses were incubated with sCD4 (10 g/ml) at
37 °C for 30 min before infection.
Human Monocyte and Macrophage Transfection—107 of
fresh isolated primary monocytes or primary macrophages dif-
ferentiated by 20 ng/ml of M-CSF were nucleofected with 30
pmol of control siRNA, siRNA for NLRP3, or siRNA for ASC.
The nucleofected cells were cultured for 48 h before infection.
All siRNAs used were from Ambion.
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Real-time PCR—Real-time PCR was performed to detect
NLRP3, ASC, and 18 S rRNA expression by TaqMan gene
expression assays (Hs00918082_m1, Hs00203118_m1, and
Hs99999901_s1) (Applied Biosystems, Carlsbad, CA) and
TLR7, TLR8, IL-1, and GAPDH expression by SYBR Green
and the following primers: TLR7, 5-AAACTCCTTGGGGCT-
AGATG-3 (forward) and 5-AGGGTGAGGTTCGTGGT-
GTT-3 (reverse); TLR8, 5-CTGTGAGTTATGCGCCGA-
AGA-3 (forward) and 5-TGGTGCTGTACATTGGGGTTG-3
(reverse); IL-1, 5-ACAGTGGCAATGAGGATGAC-3 (for-
ward) and 5-CCATGGCCACAACAACTGA-3 (reverse); and
GAPDH, 5-ATGTTCGTCATGGGTGTGAA-3 (forward)
and 5-GTCTTCTGGGTGGCAGTGAT-3 (reverse).
ELISA—Cell-free supernatants were analyzed for IL-1
expression using an IL-1 ELISA kit (BD Biosciences) accord-
ing to the instructions of the manufacturer.
ROS Detection—THP-1 cells were infected with HIV-1 and,
at different time points after infection, cells were loaded with 10
M fluoroprobe dihydrorhodamine 123 (AnaSpec, Fremont,
CA) for 30 min and washed twice with Hanks’ balanced salt
solution containing calcium and magnesium but no phenol red.
Cells were fixed with 10% formalin, and the mean fluorescence
intensity was determined using a CyAn ADP flow cytometer
(DAKO, Carpinteria, CA).
Detection of Caspase-1 Activation—THP-1 cells were
infected with HIV-1 and loaded with caspase-1 FLICA (Immu-
nochemistry Technologies, Bloomington, MN) at 3 dpi accord-
ing to the instructions of the manufacturer. Caspase-1-positive
cells were determined by a CyAn ADP flow cytometer (DAKO).
Statistics—Data are presented as the mean  S.E. Data were
analyzed for statistical significance by two-tailed Student’s t test
in Excel (Microsoft). In all cases, p  0.05 was considered to be
statistically significant.
RESULTS
HIV-1 Infection Induces IL-1 Production in human Mono-
cytic Cells—To test whether HIV-1 infection of monocytes/
macrophages can induce IL-1 production, we used the
CXCR4/CCR5 dual tropic HIV-R3A virus, which infects both T
cells and macrophages (40, 41). HIV-R3A induced a significant
increase of IL-1 in THP-1 (a human monocytic cell line) in a
dose-dependent manner (Fig. 1A). To confirm this in primary
human cells, we infected enriched primary monocytes from
human PBMCs (80% CD14). At 24 hpi, IL-1 in the super-
FIGURE 1. HIV-1 induces IL-1 production in human monocytic cells. A, THP-1 cells were infected with different doses of HIV-R3A or mock stock, and IL-1
in the supernatant was measured at 3 dpi. B, human primary monocytes from different donors were infected with mock or HIV-R3A, and IL-1 in the culture
supernatant was measured at 1 dpi. C, primary macrophages differentiated from monocytes (MDM) were mock-infected or infected with HIV-R3A or HIV-YU2,
and IL-1 in the culture supernatant was measured at 3 dpi. D, THP-1 cells were mock-infected or infected with HIV-R3A in the presence of sCD4. IL-1 in the
supernatant was measured. Data are mean  S.E. (n 	 3). **, p  0.01.
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natant was significantly increased in HIV-1-infected mono-
cytes (Fig. 1B) from three different human blood donors. When
monocyte-derived macrophages were tested, HIV-R3A infec-
tion also significantly induced IL-1 production (Fig. 1C). A
CCR5-tropic and macrophage-tropic HIV-1 strain, YU2, was
also able to induce IL-1 production in primary macrophages
(Fig. 1C). We used soluble CD4 (sCD4) to block HIV-R3A
infection of THP-1 cells (Fig. 1D). The data showed that block-
age of HIV-R3A infection by sCD4 significantly inhibited IL-1
production (Fig. 1D). Therefore, we conclude that HIV-1 infec-
tion of monocytes/macrophages efficiently induced production
of IL-1.
HIV-1 Infection Induces Pro-IL-1 Expression and Caspase-1
Activation to Promote IL-1 Production—Production of
mature IL-1 requires two signals. One activates the expression
of pro-IL-1, and the other activates the inflammasome and
interleukin-1 converting enzyme caspase-1, which cleaves pro-
IL-1 into mature IL-1 (13). IL-1 production induced by
HIV-R3A was attenuated dramatically by a pan-caspase inhib-
itor, Z-VAD-fmk, and by the caspase-1-specific inhibitor Ac-
YVAD-CHO (Fig. 2A). We also measured the level of active
caspase-1 in HIV-R3A-infected THP-1 cells by flow cytometer
with the fluorescent labeled caspase-1 inhibitor (FLICA). HIV-
R3A infection significantly increased the percentage of cells
with activated caspase-1 (Fig. 2B). These data indicate that
HIV-R3A infection activated caspase-1 to promote IL-1 pro-
duction. In the cell lysate, we detected an increase of pro-IL-1
in HIV-R3A-infected THP-1 cells (Fig. 2C), indicating that
HIV-1 infection induced expression of pro-IL-1. In addition,
infected cells treated with Ac-YVAD-CHO accumulated
more pro-IL-1 in the cytoplasm (Fig. 2D), indicating that Ac-
YVAD-CHO did not affect pro-IL-1 induction but inhibited
the activation of caspase 1 to generate mature IL-1. Consis-
tently, Ac-YVAD-CHO did not affect HIV-R3A infection of
THP-1 cells (data not shown). Furthermore, we detected the
active caspase-1 p10 and mature IL-1 p17 in the supernatant
from HIV-R3A-infected THP-1 cells but not from mock cells
(Fig. 2D). Importantly, blockage of HIV-R3A infection of
THP-1 with sCD4 abolished both pro-IL-1 induction and
caspase-1 activation (Fig. 2D). We conclude that HIV-1 infec-
tion of monocytes induces pro-IL-1 expression and caspase-1
activation to promote IL-1 production.
TLR8 Is Required for HIV-1-induced Pro-IL-1 Expression—
HIV-1 RNA is reported to activate TLR7 in plasmacytoid den-
FIGURE 2. HIV-1 induces pro-IL-1 expression and caspase-1 activation to promote IL-1 production. A, THP-1 cells were mock-infected or infected with
HIV-R3A in the absence or presence of the pan-caspase inhibitor Z-VAD-fmk (zVAD, 25 or 50 M) and the caspase-1-specific inhibitor Ac-YVAD-CHO (25 M or
50 M). IL-1 in the supernatant was measured. Data are mean  S.E. (n 	 3). Statistical analysis was performed between the HIV-1 group and the HIV-1 plus
Z-VAD-fmk or Ac-YVAD-CHO group. **, p  0.01. DMSO, dimethyl sulfoxide. B, activation of caspase-1 in HIV-R3A-infected THP-1 cells was determined by FLICA
staining. C, immunoblotting was performed to determine activated caspase-1 (p10) and mature IL-1 (p17) in supernatants (SN) and pro-IL-1 and pro-
caspase-1 in cell lysates (cell) from mock- or HIV-R3A-infected THP-1 cells. -actin was used as the loading control. The effect of AC-YVAD-CHO and soluble CD4
on caspase-1 activation and IL-1 production was also determined. The results are representative of two independent experiments.
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dritic cell (10). However, the ssRNA40 RNA derived from
HIV-1 has also been reported to promote TNF production via
TLR8, but not TLR7, in macrophages (9). We investigated
whether TLR7 or TLR8 was required for the induction of pro-
IL-1. Preventing acidification of the endosome by chloroquine
inhibits the function of endosomal TLRs (42, 43). Chloroquine
blocked HIV-1- induced pro-IL-1 expression (Fig. 3A) and
IL-1 production (Fig. 3, B and C). To define the role of TLR7
and TLR8 in HIV-1-induced pro-IL-1 expression, shRNA was
used to knock down their expression in THP-1 cells (Fig. 3D).
Interestingly, knockdown of TLR8 abolished pro-IL-1 induc-
tion in HIV-1-infected THP-1 cells, whereas knockdown of
TLR7 did not change pro-IL-1 induction (Fig. 3, E and F).
Consistently, mature IL-1 from supernatants was also
reduced dramatically in TLR8, but not TLR7, knockdown cells
(Fig. 3G). Furthermore, we found that knockdown of down-
stream MyD88 and TRAF6 also dramatically attenuated pro-
IL-1 expression (Fig. 3H) and IL-1 production (Fig. 3I)
induced by HIV-R3A infection. In conclusion, the TLR8/
MyD88/TRAF6 pathway is required for HIV-1-induced pro-
IL-1 expression in human monocytic cells.
The NLRP3 Inflammasome Is Required for HIV-1-induced
IL-1 Maturation and Release—To determine whether the
NLRP3 inflammasome is involved in HIV-1-induced IL-1
production, we utilized shRNA to inhibit NLRP3 or ASC gene
expression to assess the contribution of NLRP3 or ASC (36, 37).
Control THP-1 and knockdown cell lines were infected with
mock or HIV-R3A. HIV-R3A induced a significant increase of
FIGURE 3. TLR8 is required for HIV-induced pro-IL-1 expression. A and B, THP-1 cells were mock-infected or infected with HIV-R3A in the absence or
presence of chloroquine (CQ). qPCR analysis of pro-IL-1 mRNA (A) and ELISA analysis of supernatant IL-1 (B) were performed. C, primary monocytes were
mock-infected or infected with HIV-R3A in the absence or presence of chloroquine, and IL-1 in the supernatant was measured. D, qPCR analysis of the TLR7 or
TLR8 mRNA level in THP-1 cells containing shRNA for luciferase, TLR7, or TLR8. E–G, THP-1 cells stably transduced with lentivirus-based shRNA for luciferase
(shLuc), TLR7, or TLR8 were mock-infected or infected with HIV-R3A. Pro-IL-1 mRNA was measured by qPCR (E), pro-IL-1 protein in the cell lysate was
measured by Western blot analysis (F), and IL-1 in the supernatant was measured by ELISA (G). H and I, THP-1 cell lines expressing shRNA for MyD88 or TRAF6
(and their control mutant shRNA, mut) were mock-infected or infected with HIV-R3A. Pro-IL-1 protein in the cell lysate (H) and IL-1 in the supernatant (I) were
assessed. Data are mean  S.E. (n 	 3). **, p  0.01; n.s., not significant; KD, kilodalton. The results are representative of two independent experiments.
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IL-1 in parental THP-1 cells and cells transduced with scram-
bled control shRNA. As expected, a reported NLRP3 agonist,
R848 (18), failed to induce IL-1 production in THP1 cells
transduced with shRNA targeting NLRP3 or ASC (data not
shown). HIV-R3A also failed to induce IL-1 production in
cells with suppressed expression of NLRP3 or ASC (Fig. 4A).
However, inhibition of NLRC4 expression (75%, data not
shown) did not affect IL-1 production induced by HIV-1
infection (Fig. 4A). Furthermore, HIV-1 infection still induced
expression of pro-IL-1 in cells with suppressed expression of
NLRP3, ASC, or NLRC4 (Fig. 4B), suggesting that the NLRP3-
ASC inflammasome is not involved in HIV-1-induced pro-
IL-1 expression. Therefore, HIV-1 infection activated the
NLRP3 inflammasome to induce IL-1 maturation and release.
To confirm that NLRP3 and ASC are required in HIV-R3A-
induced IL-1 production in primary monocytes, we trans-
fected primary monocytes purified from human PBMC with
siRNA targeting NLRP3 and ASC. A scrambled siRNA was also
included as a control. The transfection efficiency of primary
monocytes was greater than 90% (data not shown). These cells
were infected with HIV-R3A, and IL-1 was measured in
supernatants collected at 24 hpi. Knockdown of NLRP3 and
ASC in primary monocytes was confirmed by quantitative PCR
(Fig. 4, C and D). The induction of IL-1 by R848 stimulation
was also attenuated significantly in primary monocytes trans-
fected with siRNA targeting NLRP3 and ASC, indicating that
NLRP3 and ASC were functionally knocked down (data not
shown). As shown above, HIV-1 infection induced a significant
increase of IL-1 in monocytes transfected with control siRNA.
In monocytes transfected with the siRNA for NLRP3 or ASC,
IL-1 induction by HIV-1 infection was attenuated signifi-
cantly (Fig. 4E). Consistently, we also found that knockdown of
NLRP3 or ASC in primary macrophages abolished HIV-1-in-
duced IL-1 production (Fig. 4F). These data suggest that
HIV-1 induces IL-1 production via the NLRP3 inflammasome
in primary monocytes/macrophages.
NLRP3 Inflammasome Activation in Responses to HIV-1 Is
Dependent on ROS Production and Cathepsin B—The induc-
tion of ROS is often critical for inflammasome activation (44,
45). To test whether HIV-R3A infection induced ROS genera-
tion, we loaded THP-1 cells with the ROS dye dihydrorhod-
amine 123 at different time points post-infection. ROS levels
increased over time during HIV-1 infection and reached a peak
at 48 hpi (Fig. 5A). We showed that ROS was essential for HIV-
1-induced IL-1 production because IL-1 secretion was
totally inhibited by APDC, an NADPH oxidase inhibitor, in
both THP-1 cells (Fig. 5B) and primary monocytes (Fig. 5C). A
specific lysosomal cysteine protease, cathepsin B, has been
reported to be associated with NLRP3 inflammasome activa-
tion and IL-1 production. Utilizing the cathepsin B-specific
inhibitor CA-074-Me, we observed a significant attenuation in
IL-1 release after HIV-R3A infection in both THP-1 cells (Fig.
5D) and primary monocytes (Fig. 5E). However, both ROS and
cathepsin B inhibitors failed to inhibit HIV-R3A-induced pro-
IL-1 expression (Fig. 5F). However, they inhibited caspase-1
activation (Fig. 5G). Therefore, HIV-1 induced ROS production
FIGURE 4. The NLRP3-ASC inflammasome is required for HIV-induced IL-1 production. A and B, control THP-1 cells or THP-1 cells expressing scramble
shRNA or shRNA for ASC, NLRP3, and NLRC4 were mock-infected or infected with HIV-R3A. IL-1 in the supernatant (A) and pro-IL-1 mRNA in the cell (B) were
assessed. C and D, human primary monocytes were nucleofected with scramble siRNA, siRNA for NLRP3, or siRNA for ASC, and mRNAs of NLRP3 (C) or ASC (D)
were measured by qPCR. E and F, human primary monocytes (E) or macrophages (F) were nucleofected with scramble siRNA, siRNA for NLRP3, or siRNA for ASC.
48 h after nucleofection, cells were mock-infected or infected with HIV-R3A. IL-1 in the supernatant was measured. Data are mean  S.E. (n 	 3). **, p  0.01;
n.s., not significant; MDM, monocyte-derived macrophages. The results are representative of three independent experiments.
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and cathepsin B activity are required for NLRP3 inflammasome
activation.
Productive Infection Is Required for HIV-1-induced Pro-IL-1
Expression and NLRP3 Inflammasome Activation—HIV-R3A-
induced IL-1 production was not significantly detectable until
48 hpi (Fig. 6, A and B). Consistently, pro-IL-1 expression and
caspase-1 activation started to be detectable at 48 hpi (Fig. 6B).
By HIV-1 p24 staining, we found that about 50% of cells were
positive at 48 hpi (data not shown). The kinetics of viral repli-
cation and pro-IL-1/IL-1 production were similar, implying
FIGURE 5. ROS and cathepsin B are required for HIV-1-induced IL-1 production. A, ROS production was determined by flow cytometry using the
fluoroprobe dihydrorhodamine 123 in mock- or HIV-R3A-infected THP-1 cells at different hpi. Data are presented as increasing fold of mean fluorescence
intensity (MFI) compared with mock. Data are mean  S.E. (n 	 3). B and C, ROS are critical for HIV-1-induced IL-1 production. ELISA was performed for IL-1
in culture supernatant from mock- or HIV-R3A-infected THP-1 cells (B) or primary monocytes (C) in the absence or presence of the ROS inhibitor APDC. D and
E, cathepsin B is critical for HIV-1-induced IL-1 production. ELISA was performed for IL-1 in culture supernatant from mock- or HIV-R3A-infected THP-1 cells
(D) or primary monocytes (E) in the absence or presence of the cathepsin B inhibitor CA-074 Me. F, qPCR analysis of pro-IL-1 mRNA in mock- or HIV-R3A-
infected THP-1 cells in the absence or presence of APDC or CA-074 Me. G, activation of caspase-1 in HIV-R3A-infected THP-1 cells was determined by FLICA
staining in the absence or presence of APDC or CA-074 Me. Data are presented as fold increase compared with mock infection. Data are mean  S.E. (n 	 3).
**, p  0.01. The results are representative of three experiments.
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that virus-productive infection may be important for HIV-1-
induced pro-IL-1 expression and NLRP3-ASC-caspase-1 acti-
vation. To assess which step of viral replication is important for
HIV-1-induced pro-IL-1 expression and inflammasome acti-
vation, we used T20 to block HIV-1 fusion, NVP and AZT to
block HIV-1 reverse transcription, raltegravir to block HIV-1
integration, and amprenavir to block HIV-1 protease activity
for viral polyprotein cleavage and viral particle maturation. All
inhibitors, except the protease inhibitor amprenavir, significantly
attenuated IL-1 release (Fig. 6C) and pro-IL-1 induction (Fig.
6D) in HIV-R3A-infected THP-1 cells. We also assessed caspase-1
activation by FLICA staining in the presence of HIV-1 inhibitors.
Although T20, NVP, AZT, and raltegravir reduced the activity of
caspase-1 to the level of mock infection, amprenavir only slightly
reduced caspase-1 activation (Fig. 6E). Consistently, T20, NVP,
AZT, and raltegravir, but not amprenavir, significantly attenuated
HIV-R3A induced IL-1 production in primary monocytes (Fig.
6F). These data indicate that post-integration products, including
HIV-1 RNA or proteins, are required for pro-IL-1 expression and
NLRP3 inflammasome activation.
HIV-1 RNA Is Sufficient to Induce Pro-IL-1 Expression and
NLRP3 Inflammasome Activation—TLR8, a sensor of single-
stranded RNA, is critical for HIV-1 induced pro-IL-1 expres-
sion (Fig. 3). ssRNA40 is a 20-mer, U-rich, single-stranded RNA
derived from the HIV-1 long terminal repeat U5 region, which
has been reported to be a TLR8 agonist. ssRNA41 is derived
from ssRNA40 by replacement of all U nucleotides with
adenosines and is used as a negative control for ssRNA40 (46).
We transfected the HIV-1-derived single-stranded RNA,
ssRNA40, or the control ssRNA41 RNA into THP-1 cells. Com-
pared with the control, ssRNA40 induced dramatic production
of pro-IL-1, active caspase-1 p10, and cleaved IL-1 p17 (Fig.
7A), indicating that HIV-1-derived RNA is sufficient for both
pro-IL-1 expression and caspase-1 activation. Furthermore,
ssRNA40-induced caspase-1 activation and IL-1 release were
abolished in NLRP3 and ASC knockdown THP-1 cells (Fig. 7, B
and C). However, ssRNA40-induced pro-IL-1 expression was
not affected in THP-1 cells with attenuated NLRP3 and ASC
expression (Fig. 7D). Even though the ssRNA40 RNA was trans-
fected into the cytosol, its induction of pro-IL-1 was still
dependent on TLR8 (Fig. 7E), which is consistent with the data
in Fig. 3. Our data suggest that HIV-1 RNAs produced after the
integration of the HIV-1 proviral genome can induce pro-IL-1
expression and activate the NLRP3 inflammasome.
DISCUSSION
HIV-1 disease progression is associated with elevated levels
of inflammatory cytokines such as IL-1. However, the mech-
FIGURE 6. HIV-1-productive infection is required for inflammasome activation. A, THP-1 cells were mock-infected or infected with HIV-R3A. IL-1 in the cell
free supernatant was assessed from 1–3 dpi. B, THP-1 cells were mock-infected or infected with HIV-R3A. Pro-IL-1, mature IL-1 (p17), pro-caspase-1, and
caspase-1 (p10) in cell lysates from 1–3 dpi were determined by Western blot analysis. -actin was used as the loading control. C–E, THP-1 cells were
mock-infected or infected with HIV-R3A in the absence or presence of various HIV-1 inhibitors (T20, NVP, AZT, raltegravir, or amprenavir). IL-1 from superna-
tant was measured by ELISA (C), pro-IL-1 mRNA was measured by qPCR (D), and caspase-1 activation was determined by FLICA staining (E). F, primary
monocytes were mock-infected or infected with HIV-R3A in the absence or presence of various HIV-1 inhibitors (T20, NVP, AZT, raltegravir, or amprenavir). IL-1
from supernatant was measured by ELISA. Data are mean  S.E. Statistical analysis was performed between HIV-1 and each HIV-1 plus virus inhibitor group (n 	
3). **, p  0.01; n.s., not significant. The results are representative of two experiments.
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anism by which HIV-1 infection leads to IL-1 production is
not clear. IL-1 production requires both the induction of pro-
IL-1 gene expression and activation of the inflammasome
complex (13). We report here that HIV-1 infection induced
expression of pro-IL-1 through TLR8-dependent mecha-
nisms and IL-1 maturation via NLRP3 inflammasome-depen-
dent mechanisms in human monocytic cells. Interestingly,
HIV-1 replication steps, including entry, reverse transcription,
and integration, but not virion maturation, were all required.
We report that HIV-1-induced ROS and cathepsin B were
required for the activation of the NLRP3 inflammasome. It has
been reported previously that there are no differences in the
IL-1 pattern in HIV-1-infected versus non-infected mono-
cytes (47– 49). The discrepancy is probably due to the different
HIV-1 strains or the lower multiplicity of infection used in pre-
vious experiments.
During influenza virus infection, viral genomic RNA is endo-
cytosed to activate TLR7 in the endosome of monocytes, which
induces pro-IL-1 gene expression (25). In this study, soluble
CD4 completely abrogated both the induction of pro-IL-1
expression and caspase-1 activation by HIV-1. We discovered
that HIV-1 infection induced pro-IL-1 expression via TLR8,
but not TLR7, in monocytes, although both TLR7 and TLR8
can be activated by HIV-1 infection (8 –12). As expected, inhib-
itors of endosome acidification, which can disrupt endosomal
TLR function, also blocked HIV-induced pro-IL-1 expression.
The NLRP3 inflammasome is activated by a number of dif-
ferent stimuli, but the molecular mechanisms are undefined
(15). It is not clear how HIV-1 infection activates the NLRP3
inflammasome, although cathepsin B activity and induction of
ROS were required. We show that HIV-1-productive infection
was required for both pro-IL-1 expression and inflammasome
activation, suggesting a novel mechanism for inflammasome
activation and IL-1 production. We quantified the total HIV-1
RNA in the cell and found that the cathepsin B inhibitor
CA-074 Me did not affect HIV-1 RNA accumulation, whereas
chloroquine and the ROS inhibitor APDC only slightly reduced
HIV-1 RNA expression, thus excluding the possibility that the
inhibition of pro-IL-1 by chloroquine and inhibition of
NLRP3 inflammasome activation and IL-1 production by
APDC or CA-074 Me is due to the inhibition of HIV-1 replica-
tion. Specific HIV-1-derived RNAs and/or HIV-1-encoded
proteins may contribute to inflammasome activation. For the
influenza virus, activation of the NLRP3 inflammasome
requires the virus-encoded M2 protein, a proton-selective ion
channel protein (25). Of interest is the HIV-1 accessory protein
Vpu, whose transmembrane domain also acts as an ion channel
(50). Expression of each HIV-1 encoded ORF alone in THP1
cells and primary macrophages showed no significant effect on
inflammasome activation.3 However, transfection of HIV-1-
derived single-stranded RNA into THP-1 cells induced signifi-
cant caspase-1 activation and IL-1 production. It seems that
HIV-1 activates NLRP3 through its RNA but not the ion chan-
nel protein Vpu. It is possible that HIV-1 RNA accumulation
triggered ROS production and cathepsin B release from the
lysosome, which contribute to NLRP3 inflammasome activa-
tion. It will be interesting to define the specific HIV-1 RNA
3 Guo, H., and Su, L., unpublished data.
FIGURE 7. HIV-1-derived RNA is sufficient for pro-IL-1 expression and NLRP3 inflammasome activation. A, THP-1 cells were transfected with HIV-1-
derived single-stranded RNA ssRNA40 or control RNA ssRNA41. Pro-IL-1, mature IL-1 (p17), pro-caspase-1, and caspase-1 (p10) were detected in cell lysates
(cell) and mature IL-1 (p17) and caspase-1 (p10) were detected in the supernatant (sn) by Western blot analysis. KD, kilodalton. B–D, THP-1 cells expressing
scramble shRNA or shRNA for ASC or NLRP3 were transfected with ssRNA41 or ssRNA40. B, IL-1 process and caspase-1 activation were determined by Western
blot analysis. IL-1 in the supernatant (C) and pro-IL-1 mRNA in the cell (D) were also assessed by ELISA and qPCR. E, THP-1 cells expressing shRNA for luciferase
or TLR8 were transfected by vehicle or ssRNA40. Pro-IL-1 mRNA in the cell was determined by qPCR. Data are mean  S.E. (n 	 3). The results are representative
of two experiments.
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sequences and the receptors required for HIV-1-induced
NLRP3 inflammasome activation in future experiments.
Consistent with our findings, HIV-1 disease progression is
associated with activated macrophages and increased levels of
IL-1 (51), which likely lead to immune dysregulation and CD4
T cell depletion. Therefore, reducing the IL-1 level or activ-
ity in vivo is likely beneficial to HIV-1 patients. This hypoth-
esis will be tested in the humanized mouse models of HIV
pathogenesis (52–54) or in the simian immunodeficiency
virus-infected rhesus monkey models (55–58) using IL-1-
neutralizing antibodies.
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